A detailed history of Israel Englander (Millennium Management LLC) transactions in Novo Cure LTD stock. As of the latest transaction made, Millennium Management LLC holds 300,000 shares of NVCR stock, worth $9.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300,000
Previous 1,205,892 75.12%
Holding current value
$9.53 Million
Previous $20.7 Million 77.3%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.61 - $23.34 $14.6 Million - $21.8 Million
-935,081 Reduced 77.54%
270,811 $4.23 Million
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $206,670 - $420,153
-17,470 Reduced 1.43%
1,205,892 $20.7 Million
Q1 2024

May 15, 2024

BUY
$12.42 - $17.29 $2.04 Million - $2.84 Million
164,222 Added 15.51%
1,223,362 $19.1 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $11.3 Million - $16 Million
1,014,324 Added 2263.31%
1,059,140 $15.8 Million
Q2 2023

Aug 14, 2023

BUY
$40.29 - $82.51 $1.14 Million - $2.33 Million
28,265 Added 170.78%
44,816 $1.86 Million
Q1 2023

May 15, 2023

BUY
$56.44 - $118.81 $934,138 - $1.97 Million
16,551 New
16,551 $995,000
Q3 2022

Nov 14, 2022

SELL
$67.99 - $89.57 $5.43 Million - $7.16 Million
-79,897 Reduced 95.53%
3,738 $284,000
Q2 2022

Aug 15, 2022

BUY
$56.6 - $89.9 $4.57 Million - $7.26 Million
80,778 Added 2827.37%
83,635 $5.81 Million
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $7.63 Million - $10.7 Million
-126,841 Reduced 97.8%
2,857 $237,000
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $9.5 Million - $15.4 Million
126,574 Added 4051.66%
129,698 $9.74 Million
Q3 2021

Nov 15, 2021

SELL
$116.17 - $194.55 $934,355 - $1.56 Million
-8,043 Reduced 72.02%
3,124 $363,000
Q2 2021

Aug 16, 2021

SELL
$130.4 - $225.58 $13.5 Million - $23.4 Million
-103,541 Reduced 90.26%
11,167 $2.48 Million
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $8.44 Million - $13.1 Million
75,265 Added 190.82%
114,708 $19.8 Million
Q3 2020

Nov 16, 2020

SELL
$58.05 - $111.31 $13.3 Million - $25.5 Million
-229,536 Reduced 85.34%
39,443 $4.39 Million
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $15.1 Million - $19.7 Million
264,373 Added 5739.75%
268,979 $16 Million
Q1 2020

May 14, 2020

BUY
$57.05 - $95.75 $262,772 - $441,024
4,606 New
4,606 $310,000
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $1.48 Million - $2.04 Million
-21,697 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$61.86 - $97.8 $2.4 Million - $3.79 Million
-38,718 Reduced 64.09%
21,697 $1.62 Million
Q2 2019

Aug 14, 2019

SELL
$42.22 - $63.23 $2.54 Million - $3.81 Million
-60,212 Reduced 49.92%
60,415 $3.82 Million
Q1 2019

May 14, 2019

BUY
$31.96 - $56.12 $3.86 Million - $6.77 Million
120,627 New
120,627 $5.81 Million
Q4 2018

Feb 14, 2019

SELL
$28.72 - $52.63 $363,911 - $666,874
-12,671 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$32.0 - $52.4 $4.51 Million - $7.38 Million
-140,794 Reduced 91.74%
12,671 $664,000
Q2 2018

Aug 14, 2018

SELL
$19.85 - $32.0 $1.87 Million - $3.01 Million
-93,959 Reduced 37.97%
153,465 $4.8 Million
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $4.58 Million - $5.61 Million
-237,145 Reduced 48.94%
247,424 $5.39 Million
Q4 2017

Feb 14, 2018

BUY
$16.3 - $21.9 $1.7 Million - $2.28 Million
104,210 Added 27.4%
484,569 $9.79 Million
Q3 2017

Nov 14, 2017

BUY
$18.05 - $21.75 $6.87 Million - $8.27 Million
380,359
380,359 $7.55 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.33B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.